Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...

“ [These] strong phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in ...

The S&P 500 fell 0.1% on Tuesday, July 8, 2025, after President Trump extended the deadline for "reciprocal" tariffs and ...

According to the CDC, there has been a decline in animal infections and no reports of human cases since February.

The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The S&P 500’s biggest gainer was Moderna Inc (BMV: MRNA) up more than 9% after leading medical organizations filed a lawsuit ...

The Dow Jones Industrial Average (DJI) is down more than 131 points this afternoon, while the Nasdaq Composite (IXIC) and S&P 500 Index (SPX) are trading slightly below breakeven amid mixed messages ...

View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...

Citing a drop in case numbers, the Centers for Disease Control and Prevention (CDC) has ended its emergency response to the H5N1 bird flu outbreak, which has affected hundreds of millions of birds and ...

Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant ...